RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
+3.35%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-77.1%
Return on equity
-68.8%
Return on assets
-81.6%
Return on invested capital
0.00x
Asset turnover
-$64.6M
Cash from operations
$1.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026